Abstract
Sulfa drugs are well known blockers of folate synthesis, acting as competitive inhibitors of p-aminobenzoate (pABA). Their mimicry of pABA is so complete that they can also condense with 2-amino-4-hydroxy-6-hydroxymethyl-7,8 dihydropteridine pyrophosphate to form sulfa-dihydropteroate (sulfa-DHP), which are inhibitory through competition with dihydrofolate. This suggests that, in addition to dihydropteroate synthase, there are still undiscovered determinants involved in sulfa drug resistance. Furthermore, novel drugs based on the DHP analogues could be added to the armory of antifolate drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 1-3 |
| Number of pages | 3 |
| Journal | Trends in Parasitology |
| Volume | 20 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2004 |
| Externally published | Yes |
Bibliographical note
Funding Information:We thank Lindsay Sparrow and Ross Fernley for their critical reading of this manuscript. A.N. and E.M. thank The Wellcome Trust of Great Britain for financial support (ref. no. 056769).
ASJC Scopus subject areas
- Parasitology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Sulfa drugs strike more than once'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver